Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Clinical Pharmacology and Therapeutics
|
May 1, 1997
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test
C L Cheng, D E Smith, P L Carver, et al.
Neurobiology of Aging
|
May 22, 2021
Associations between total MRI-visible small vessel disease burden and domain-specific cognitive abilities in a community-dwelling older-age cohort
Okl Hamilton, S R Cox, L Ballerini, et al.
Scientific Reports
|
February 11, 2017
Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank
L M Reus, X Shen, J Gibson, et al.
Annals of the Rheumatic Diseases
|
March 13, 2014
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial
J L Nam, E Villeneuve, E M A Hensor, et al.
Journal for the Measurement of Physical Behaviour
|
August 31, 2018
Characteristics of a protocol to collect objective physical activity/sedentary behaviour data in a large study: Seniors USP (understanding sedentary patterns)
P M Dall, D A Skelton, M L Dontje, et al.
IJTLD Open
|
May 14, 2025
Patient and provider preferences for long-acting TB preventive therapy
M Vermeulen, K K Scarsi, R Furl, et al.
Translational Psychiatry
|
April 29, 2020
Psychotic-like experiences, polygenic risk scores for schizophrenia, and structural properties of the salience, default mode, and central-executive networks in healthy participants from UK Biobank
C Alloza, M Blesa-Cábez, M E Bastin, et al.
Neuroimage
|
September 5, 2018
Polygenic risk score for schizophrenia and structural brain connectivity in older age: A longitudinal connectome and tractography study
C Alloza, S R Cox, M Blesa Cábez, et al.
Translational Psychiatry
|
July 6, 2021
Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936
O K L Hamilton, S R Cox, J A Okely, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients
R T Davey, D G Chaitt, G F Reed, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Clinical Pharmacology and Therapeutics
|
May 1, 1997
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test
C L Cheng, D E Smith, P L Carver, et al.
Neurobiology of Aging
|
May 22, 2021
Associations between total MRI-visible small vessel disease burden and domain-specific cognitive abilities in a community-dwelling older-age cohort
Okl Hamilton, S R Cox, L Ballerini, et al.
Scientific Reports
|
February 11, 2017
Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank
L M Reus, X Shen, J Gibson, et al.
Annals of the Rheumatic Diseases
|
March 13, 2014
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial
J L Nam, E Villeneuve, E M A Hensor, et al.
Journal for the Measurement of Physical Behaviour
|
August 31, 2018
Characteristics of a protocol to collect objective physical activity/sedentary behaviour data in a large study: Seniors USP (understanding sedentary patterns)
P M Dall, D A Skelton, M L Dontje, et al.
IJTLD Open
|
May 14, 2025
Patient and provider preferences for long-acting TB preventive therapy
M Vermeulen, K K Scarsi, R Furl, et al.
Translational Psychiatry
|
April 29, 2020
Psychotic-like experiences, polygenic risk scores for schizophrenia, and structural properties of the salience, default mode, and central-executive networks in healthy participants from UK Biobank
C Alloza, M Blesa-Cábez, M E Bastin, et al.
Neuroimage
|
September 5, 2018
Polygenic risk score for schizophrenia and structural brain connectivity in older age: A longitudinal connectome and tractography study
C Alloza, S R Cox, M Blesa Cábez, et al.
Translational Psychiatry
|
July 6, 2021
Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936
O K L Hamilton, S R Cox, J A Okely, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients
R T Davey, D G Chaitt, G F Reed, et al.
Page
of 6